Seymour H. Fein

Seymour H. Fein

Chief Tech/Sci/R&D Officer chez ONCOTELIC THERAPEUTICS, INC.

75 ans
Health Technology
Consumer Services
Finance

Profil

Seymour H.
Fein
is the founder of Serenity Pharmaceuticals Corp.
(founded in 2007) where he holds the title of Chief Medical Officer & Principal.
He is currently the Chief Medical & Regulatory Officer at Oncotelic Therapeutics, Inc. (since 2022) and the Chief Medical Officer at Ventria Bioscience, Inc. (since 2015).
In his former positions, he served as a Medical Director at Bayer Pharmaceuticals Corp., Bayer HealthCare Pharmaceuticals, Inc., Ohmeda PPD, Inc., Rorer Group, Inc., and Ohmeda, Inc. He was also a Director-Clinical Research & Development at Ohmeda PPD, Inc. Additionally, he held the position of Independent Director at Prospect Park Capital Corp.
from 2016 to 2020.
Dr. Fein was the Chief Medical Officer at Oncotelic Therapeutics, Inc. and Delcath Systems, Inc. from 2006 to 2008.
He also worked as a Senior Research Physician at Hoffmann-La Roche, Inc. and as a Principal at the US Food & Drug Administration.
Dr. Fein obtained his undergraduate degree from the University of Pennsylvania and his doctorate from New York Medical College.

Postes actifs de Seymour H. Fein

SociétésPosteDébut
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 28/02/2023
Chief Tech/Sci/R&D Officer 11/05/2015
Founder 01/01/2007
Tous les postes actifs de Seymour H. Fein

Anciens postes connus de Seymour H. Fein

SociétésPosteFin
PROSPECT PARK CAPITAL CORP. Director/Board Member 23/01/2020
DELCATH SYSTEMS, INC. Chief Tech/Sci/R&D Officer 17/07/2008
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
ADHERA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Bayer Pharmaceuticals Corp. Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Seymour H. Fein

Formation de Seymour H. Fein

University of Pennsylvania Undergraduate Degree
New York Medical College Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Seymour H. Fein

Relations

40

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
ONCOTELIC THERAPEUTICS, INC.

Health Technology

DELCATH SYSTEMS, INC.

Health Technology

PROSPECT PARK CAPITAL CORP.

Finance

ADHERA THERAPEUTICS, INC.

Health Technology

Entreprise privées9
Bayer Pharmaceuticals Corp.

Health Technology

Government

Health Technology

Health Technology

Ohmeda PPD, Inc.

Health Technology

Health Technology

Ohmeda, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Seymour H. Fein